Australia markets open in 6 hours 7 minutes

TFF Pharmaceuticals, Inc. (TFFP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.1100+0.1600 (+8.21%)
As of 01:30PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 6.76M
Enterprise value 2.45M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.74
Price/book (mrq)1.15
Enterprise value/revenue 5.22
Enterprise value/EBITDA -0.50

Trading information

Stock price history

Beta (5Y monthly) 1.36
52-week change 3-78.69%
S&P500 52-week change 322.62%
52-week high 311.0000
52-week low 31.3500
50-day moving average 31.9122
200-day moving average 34.3763

Share statistics

Avg vol (3-month) 337.23k
Avg vol (10-day) 325.02k
Shares outstanding 53.47M
Implied shares outstanding 63.47M
Float 82.76M
% held by insiders 14.20%
% held by institutions 122.50%
Shares short (15 Aug 2024) 4144.33k
Short ratio (15 Aug 2024) 45.18
Short % of float (15 Aug 2024) 44.22%
Short % of shares outstanding (15 Aug 2024) 44.16%
Shares short (prior month 15 July 2024) 4129k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 319 Dec 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-609.42%

Management effectiveness

Return on assets (ttm)-105.91%
Return on equity (ttm)-213.51%

Income statement

Revenue (ttm)1.2M
Revenue per share (ttm)0.47
Quarterly revenue growth (yoy)95.10%
Gross profit (ttm)N/A
EBITDA -19.01M
Net income avi to common (ttm)-19.39M
Diluted EPS (ttm)-6.8800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.39M
Total cash per share (mrq)1.27
Total debt (mrq)74.12k
Total debt/equity (mrq)1.26%
Current ratio (mrq)1.62
Book value per share (mrq)1.81

Cash flow statement

Operating cash flow (ttm)-13.61M
Levered free cash flow (ttm)-6.48M